Skip to main content

Lewis William's Form 4 filing

INSMED Inc (INSM) · filed May 20, 2026

Accession no.
0001402051-26-000030
Filed
May 20, 2026
Trade date
May 18, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $2.72M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lewis WilliamCIK 0001402051Director, Officer (Chair and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 18, 2026Common StockMOption exerciseAcquired+6,259$30.46+$190,649.14294,161Direct
May 18, 2026Common StockMOption exerciseAcquired+4,440$17.16+$76,190.4298,601Direct
May 18, 2026Common StockSSaleDisposed−5,753$105.32F2−$605,905.96292,848Direct
May 18, 2026Common StockSSaleDisposed−11,836$106.39F3−$1,259,232.04281,012Direct
May 18, 2026Common StockSSaleDisposed−7,975$106.97F4−$853,085.75273,037Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 18, 2026Common StockMOption exerciseDisposed−6,259$0.00$025,037Direct
May 18, 2026Common StockMOption exerciseDisposed−4,440$0.00$017,760Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This is the weighted average sales price representing 5,753 shares sold at prices ranging from $104.73 to $105.71 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F3

This is the weighted average sales price representing 11,836 shares sold at prices ranging from $105.73 to $106.72 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

F4

This is the weighted average sales price representing 7,975 shares sold at prices ranging from $106.73 to $107.36 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)